Evidence map›Paper›PMID 39170511›Full record

ArticleHeliyon2024

Development of a broad range of two-colour ozone indicator.

Takashi Kusaka, Shunji Ishiwata, Manami Nishioka, Yuko Okamoto, Masaki Yoshioka, Tomomi Inoue, Takeshi Kotake

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Takashi KusakaDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.
Shunji IshiwataDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.
Manami NishiokaDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.
Yuko OkamotoTamura Teco Co., Ltd, Osaka, Japan.
Masaki YoshiokaDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.
Tomomi InoueDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.
Takeshi KotakeDivision of Medical Pharmaceutics and Therapeutics, Faculty of Pharmacy, Kindai University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antiviral and antibacterial properties of ozone gas have been utilised for air and on-site disinfection. However, excess ozone gas exposure is toxic to humans, necessitating the monitoring of exposure levels. While this has been achieved using ozone indicators, determining exposure levels at intermediate time points during exposure remains challenging owing to the current ones being capable of measuring exposure only at endpoints. Shifts in the endpoint are also difficult as the coverage ranges of the indicators are dependent on a single colour dye. The indicator that covers a wide range is desirable to treat various pathogenic microorganisms. The aim of this study was to develop a two-colour ozone indicator with a broad coverage range that does not compromise the performance of the individual dyes. Exposure levels were indicated by visible changes in colour density and phase, aiding the measurement of exposure at the endpoints and during the exposure period, thereby maintaining better safety profiles for exposed individuals. Additionally, a theoretical approach for the development of two-colour indicators has been described.

Indexed as

ColourDisinfectionIndicatorOzone

Identifiers

PMID39170511
PMCPMC11336812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.